News

VIDEO: What's next for lung cancer detection and treatment?


 

In an interview at the Joint Conference on the Molecular Origins of Lung Cancer, Dr. Roy Herbst, chief of medical oncology at the Yale Cancer Center in New Haven, Conn., offers his perspectives on new developments in lung cancer screening and treatment, and he discusses the promise that genetically targeted approaches and immunotherapy may offer.

Recommended Reading

FDA approves once-daily combination treatment inhaler for COPD
MDedge Family Medicine
What Matters – Higher-dose varenicline
MDedge Family Medicine
USPSTF gives final recommendation on lung cancer screening
MDedge Family Medicine
Smoking rate among people with mental illness shows negligible decline
MDedge Family Medicine
Smoking cessation maintained with varenicline plus CBT
MDedge Family Medicine
Bupropion-varenicline combo gave harder kick to smoking habits
MDedge Family Medicine
Pediatricians, cancer groups ask regulators to help cut tobacco use
MDedge Family Medicine
CV risk in former light smokers reduced sooner than in heavy smokers
MDedge Family Medicine
Methotrexate less risky for lungs in RA than previously thought
MDedge Family Medicine
Intussusception risk seen with newer rotavirus vaccines
MDedge Family Medicine